Daxor Corp.
:DXR 10:21:59 AM EDT
| Market Cap (Intraday) | 61.19M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $10.25 |
| 50-Day MA | $10.37 |
| 200-Day MA | $11.88 |
Daxor Corp. Stock, :DXR
109 Meco Lane, 350 5th Avenue, Oak Ridge, Tennessee 37830
United States of America
Phone: +1.212.330.8500
Number of Employees:
Description
DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.